We are live on ! Find out more
SRDX

Surmodics

Delisted

SRDX was delisted on the 18th of November, 2025.

124 hedge funds and large institutions have $557M invested in Surmodics in 2024 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 31 increasing their positions, 34 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

650% more call options, than puts

Call options by funds: $1.07M | Put options by funds: $143K

300% more funds holding in top 10

Funds holding in top 10: 14 (+3)

49% more capital invested

Capital invested by funds: $374M → $557M (+$183M)

43% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 28

10% more funds holding

Funds holding: 113124 (+11)

3.41% more ownership

Funds ownership: 89.52%92.92% (+3.4%)

9% less repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 34

Holders
124
Holders Change
+11
Holders Change %
+9.73%
% of All Funds
1.79%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.06%
New
40
Increased
31
Reduced
34
Closed
28
Calls
$1.07M
Puts
$143K
Net Calls
+$929K
Net Calls Change
+$1.06M

SRDX Hedge Fund Activity: Q2 2024 in Review

124 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q2 2024, worth a combined $557M — up 49% from $374M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new SRDX positions and 28 closed out — a net gain of 12 holders — while 31 added to existing stakes and 34 trimmed.

The largest buyer was Beryl Capital Management, opening a new position worth an estimated $52.6M. The largest seller was Trigran Investments, cutting an estimated $44.8M.

  • 124 institutional investors held Surmodics (SRDX) as of Q2 2024, up from 113 in Q1 2024.
  • Funds reported $557M of Surmodics stock for Q2 2024, up 49% quarter-over-quarter.
  • 40 funds opened new Surmodics positions in Q2 2024 and 28 closed out, a net change of +12 holders.
  • The largest Surmodics buyer in Q2 2024 was Beryl Capital Management, an estimated $52.6M added.
  • The largest Surmodics seller in Q2 2024 was Trigran Investments, an estimated $44.8M sold.

Based on aggregated 13F filings for Q2 2024.